Cite
Palmela C, Velho S, Agostinho L, et al. Body Composition as a Prognostic Factor of Neoadjuvant Chemotherapy Toxicity and Outcome in Patients with Locally Advanced Gastric Cancer. J Gastric Cancer. 2017;17(1):74-87doi: 10.5230/jgc.2017.17.e8.
Palmela, C., Velho, S., Agostinho, L., Branco, F., Santos, M., Santos, M. P., Oliveira, M. H., Strecht, J., Maio, R., Cravo, M., & Baracos, V. E. (2017). Body Composition as a Prognostic Factor of Neoadjuvant Chemotherapy Toxicity and Outcome in Patients with Locally Advanced Gastric Cancer. Journal of gastric cancer, 17(1), 74-87. https://doi.org/10.5230/jgc.2017.17.e8
Palmela, Carolina, et al. "Body Composition as a Prognostic Factor of Neoadjuvant Chemotherapy Toxicity and Outcome in Patients with Locally Advanced Gastric Cancer." Journal of gastric cancer vol. 17,1 (2017): 74-87. doi: https://doi.org/10.5230/jgc.2017.17.e8
Palmela C, Velho S, Agostinho L, Branco F, Santos M, Santos MP, Oliveira MH, Strecht J, Maio R, Cravo M, Baracos VE. Body Composition as a Prognostic Factor of Neoadjuvant Chemotherapy Toxicity and Outcome in Patients with Locally Advanced Gastric Cancer. J Gastric Cancer. 2017 Mar;17(1):74-87. doi: 10.5230/jgc.2017.17.e8. Epub 2017 Mar 14. PMID: 28337365; PMCID: PMC5362836.
Copy
Download .nbib